Preparation and evaluation of a controlled drug release of repaglinide through matrix pellets: in vitro and in vivo studies

References

• Abdalla A, Mader K. Preparation and characterization of a self-emulsifying pellet formulation. Eur J Pharm Biopharm, 2007;66:220–6
   PubMed Web of Science ®Google Scholar
• Abdul S, Chandewar AV, Jaiswal SB. Flexible technology for modified-release drugs: Multiple-unit pellet system (MUPS). J Control Release, 2010;147:2–16
   PubMed Web of Science ®Google Scholar
• Bhaskaran S, Lakshmi PK. Extrusion spheronization – A review. Int J PharmTech Res, 2010;2(4):2429–33
   Google Scholar
• Chatchawalsaisin J, Podczeck F, Michael Newton J. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate. Eur J Pharm Sci, 2005;24:35–48
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 2001;13:123–33
   PubMed Web of Science ®Google Scholar
• Dhana lekshmi UM, Poovi G, Kishore N, Neelakanta Reddy P. In vitro characterization and in vivo toxicity study of Repaglinide loaded poly (methyl methacrylate) nanoparticles. Int J Pharm, 2010;396:194–203
   PubMed Web of Science ®Google Scholar
• Dukic-Ott A, Thommes M, Remon JP, Kleinebudde P, Vervaet C. Production of pellets via extrusion–spheronisation without the incorporation of microcrystalline cellulose: A critical review. Eur J Pharm Biopharm, 2009;71:38–46
   PubMed Web of Science ®Google Scholar
• Hator PV. Clinical pharmacokinetics and pharmacodynamics of Repaglinide. Clin Pharmacokinet, 2002;64:471–83
   Google Scholar
• Jain SK, Awasthi AM, Jain NK, Agrawa GP. Calcium silicate based microspheres of Repaglinide for gastro retentive floating drug delivery: Preparation and in vitro characterization. J Control Release, 2005;107:300–9
   PubMed Web of Science ®Google Scholar
• Jijun F, Xiaoli W, Lishuang X, Jia M, Yan W, Guofei L. Preparation and in vitro–in vivo evaluation of double layer coated and matrix sustained release pellet formulations of Diclofenac potassium. Int J Pharm, 2011;406:84–90
   PubMedGoogle Scholar
• Jirovsky D, Bartos-ova Z, Skopalova J, Maier V. Electrochemical characterization of Repaglinide and its determination in human plasma using liquid chromatography with dual-channel coulometric detection. J Chromatogr B, 2010;878:3243–8
   PubMedGoogle Scholar
• Kolendorf K, Eriksson J, Birkeland KI, Kjellström T, Hreidarsson AB. Dose titration of Repaglinide in patients with inadequately controlled type 2 diabetes. Diab Res Clin Pract, 2004;64:33–40
   PubMed Web of Science ®Google Scholar
• Mandic Z, Gabelica V. Ionization, lipophilicity and solubility properties of repaglinide. J Pharm Biomed Anal, 2006;41:866–71
   PubMed Web of Science ®Google Scholar
• Newton JM, Pinto MR, Podczeck F. The preparation of pellets containing a surfactant or a mixture of mono- and di-gylcerides by extrusion/spheronisation. Eur J Pharm Sci, 2007;30:333–42
   PubMed Web of Science ®Google Scholar
• O’Connor RE, Schwartz JB. Spheronization II: Drug release from drug-diluents’ mixtures. Drug Dev Ind Pharm, 1985;11:1837–57
   Web of Science ®Google Scholar
• Pai R, Kohli K. Extended release matrix pellets: Preparation and compression into disintegrating tablet. Int J Drug Deliv, 2011;3:329–39
   Google Scholar
• Prajapati ST, Patel CG, Patel CN. Formulation and evaluation of transdermal patch of Repaglinide. ISRN Pharm, 2011;2011:651909
   PubMedGoogle Scholar
• Purvis T, Mattucci ME, Crisp MT, Johnston KP. Rapidly dissolving Repaglinide powders produced by the ultra-rapid freezing process. AAPS PharmSciTech, 2007;8(3):E1–9
   PubMed Web of Science ®Google Scholar
• Rajesh N, Siddaramaiah. Design and evaluation of controlled release of Piroxicam from the pellets of microcrystalline cellulose and hydroxypropylmethyl cellulose blends. Int J PharmTech Res, 2010;2(2):1456–73
   Google Scholar
• Shah RD, Kabadi M, Pope DG, Augsburger I. Physico-mechanical characterization of the extrusion-spheronization process. Part II: Rheological determinants for successful extrusion and spheronization. Pharm Res, 1995;4:496–507
   Google Scholar
• Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 2001;48(2–3):139–57
   PubMed Web of Science ®Google Scholar
• Tavakoli N, Varshosaz J, Ghannadi AR, Bavarsad N. Evaluation of trigonella foenum-graecum seeds gum as a novel tablet binder. Int J Pharm Pharm Sci, 2007;4(1):97–101
   Google Scholar
• Tavakoli N, Varshosaz J, Dorkoosh F, Motaghi S, Tamaddon L. Development and evaluation of a monolithic floating drug delivery system for Acyclovir. Chem Pharm Bull, 2012;60(2):172–7
   PubMed Web of Science ®Google Scholar
• Tripurasundari P, Prabhakar B. Review on the production of pellets via extrusion-spheronisation exclusive of microcrystalline cellulose. Int J Pharm Rev Res, 2012;2(1):1–10
   Google Scholar
• Trivedi NR, Rajan MG, Johnson JR, Shukla AJ. Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process. Crit Rev Ther Drug Carrier Syst, 2007;24:1–40
   PubMed Web of Science ®Google Scholar
• Vijayan V, Jayachandran E, Anburaj J, Srinivasa Rao D. Transdermal delivery of Repaglinide from solid lipid nanoparticles in diabetic rats: In vitro and in vivo studies. J Pharm Sci Res, 2011;3(3):1077–81
   Google Scholar
• Vishal Gupta N, Gowda DV, Balamuralidhara V, Mohammed Khan S. Formulation and evaluation of olanzapine matrix pellets for controlled release. DARU, 2011;4:249–56
   Google Scholar
• Wang Z, Sun J, Wang Y, Liu X, Liu Y. Solid self-emulsifying Nitrendipine pellets: Preparation and in vitro/in vivo evaluation. Int J Pharm, 2010;383:1–6
   PubMed Web of Science ®Google Scholar
• Wells JI. 1988. Pharmaceutical preformulation: The physicochemical properties of drug substances, 1st edn. New York: Wiley, pp. 209–11
   Google Scholar
• Yadav D, Survase S, Kumar N. Dual coating of swellable and rupturable polymers on Glipizide loaded MCC pellets for pulsatile delivery: Formulation design and in vitro evaluation. Int J Pharm, 2011;419:121–30
   PubMed Web of Science ®Google Scholar